pfizer glp-1 agonist selects new drug for danuglipron | Pharmaceutical Business Review International posted on the topic GLP1 agonists: current and future

This circadian rhythm is regulated by food intake..

So when someone says, GLP-1s cause muscle loss, the first question should be: what exactly was measured

Research shows that nearly 90% of people with type 2 diabetes also struggle with their weight, and these medications solve both problems at once

Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.

Adverse psychiatric effects associated with GLP-1 RAs, including depression, anxiety, and suicidal ideation, are noted in pharmacovigilance analyses, with variations among different GLP-1 RAs